Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Accurate Molecular Mass(KD)
NA
Isoelectric Point
8.7
Predicted Molecular Mass(KD)
31.0kDa
Purity
≥ 95%
Group
recombinants
Protein length
Gly164~His417
Tag
N-terminal His-Tag
Traits
Freeze-dried powder
Expression System
Prokaryotic expression
Source
Prokaryotic expression
Organism species
Rattus norvegicus (Rat)
Research Area
Metabolic pathway;Hematology;
Additional source
Recombinants or rec. proteins
Application
Positive Control; Immunogen; SDS-PAGE; WB.
Item Name
Thrombin Activatable Fibrinolysis Inhibitor
Buffer Formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Alternative Names
CPB2; CPU; PCPB; Carboxypeptidase B2; Plasma Carboxypeptidase B; Carboxypeptidase U
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.